Trends in the prevalence, risk and pregnancy outcome of multiple births with congenital anomaly: a registry-based study in 14 European countries 1984-2007 by Boyle, Breidge et al.
Trends in the prevalence, risk and pregnancy
outcome of multiple births with congenital
anomaly: a registry-based study in 14 European
countries 1984–2007
BBoyle,a RMcConkey,b E Garne,c M Loane,a MC Addor,d MK Bakker,e PA Boyd,f M Gatt,g R Greenlees,a
M Haeusler,h K Klungsøyr,i A Latos-Bielenska,j N Lelong,k RMcDonnell,l J Metneki,m CMullaney,n
V Nelen,o MO’Mahony,p A Pierini,q J Rankin,r A Rissmann,s D Tucker,t DWellesley,u H Dolka
a Centre for Maternal Fetal and Infant Research, University of Ulster, Newtownabbey, UK b Centre for Intellectual and Developmental
Disabilities, University of Ulster, Newtownabbey, UK c Hospital Lillebaelt, Kolding, Denmark d Division of Medical Genetics, Lausanne,
Switzerland e Eurocat Northern Netherlands, Department of Genetics, University of Groningen, University Medical Center, Groningen,
The Netherlands f National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK g Department of Health Information and Research,
Guardamangia, Malta h Medical University of Graz, Austria i Medical Birth Registry of Norway, Bergen, Norway j Polish Registry of Congenital
Malformations, Poznan, Poland k Paris Registry of Congenital Malformations, INSERM U953, Paris, France l Health Service Executive, Dublin,
Ireland m National Institute of Health Development, Department of Hungarian Congenital Abnormality Registry & Surveillance, Budapest,
Hungary n Health Service Executive, Kilkenny, Ireland o Provinciaal Insituut voor Hygiene, Antwerp, Belgium p Health Service Executive, Cork,
Ireland q CNR Institute of Clinical Physiology, Pisa, Italy r Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
s Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University, Magdeburg, Germany t Public Health Wales,
Wales, UK u Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, Southampton, UK
Correspondence: Prof H Dolk, Centre for Maternal fetal and Infant Research, Institute of Nursing and Health Research, University of Ulster,
Shore Rd, Newtownabbey, Co. Antrim, Northern Ireland BT37 0QB. Email h.dolk@ulster.ac.uk
Accepted 10 December 2012. Published Online 6 February 2013.
Objective To assess the public health consequences of the rise in
multiple births with respect to congenital anomalies.
Design Descriptive epidemiological analysis of data from
population-based congenital anomaly registries.
Setting Fourteen European countries.
Population A total of 5.4 million births 1984–2007, of which 3%
were multiple births.
Methods Cases of congenital anomaly included live births, fetal
deaths from 20 weeks of gestation and terminations of pregnancy
for fetal anomaly.
Main outcome measures Prevalence rates per 10 000 births and
relative risk of congenital anomaly in multiple versus singleton
births (1984–2007); proportion prenatally diagnosed, proportion
by pregnancy outcome (2000–07). Proportion of pairs where both
co-twins were cases.
Results Prevalence of congenital anomalies from multiple births
increased from 5.9 (1984–87) to 10.7 per 10 000 births (2004–07).
Relative risk of nonchromosomal anomaly in multiple births was
1.35 (95% CI 1.31–1.39), increasing over time, and of
chromosomal anomalies was 0.72 (95% CI 0.65–0.80), decreasing
over time. In 11.4% of affected twin pairs both babies had
congenital anomalies (2000–07). The prenatal diagnosis rate was
similar for multiple and singleton pregnancies. Cases from
multiple pregnancies were less likely to be terminations of
pregnancy for fetal anomaly, odds ratio 0.41 (95% CI 0.35–0.48)
and more likely to be stillbirths and neonatal deaths.
Conclusions The increase in babies who are both from a multiple
pregnancy and affected by a congenital anomaly has implications
for prenatal and postnatal service provision. The contribution of
assisted reproductive technologies to the increase in risk needs
further research. The deficit of chromosomal anomalies among
multiple births has relevance for prenatal risk counselling.
Keywords Concordance, congenital anomalies, multiple births,
pregnancy outcomes, twins.
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Introduction
The proportion of multiple births has risen in the last
30 years, through changes in maternal age1 and the intro-
duction of assisted reproductive therapies (ART).2,3 This
rise is mainly in dizygotic or multizygotic deliveries (DZ),
because monozygotic (MZ) twinning is not strongly associ-
ated with either maternal age or ART.2,3 There is evidence
that multiple births have an increased risk of congenital
anomaly relative to singleton births.4–11 The excess in con-
genital anomalies has been associated with the splitting of
the zygote4,6 and with vascular accidents as a result of
blood clots or other debris moving across a shared or
joined placenta9 in MZ twins. Epidemiological studies have
found an excess risk of anomaly in MZ twins relative to
DZ twins, with the risk for DZ twins being similar to that
in singletons.4,6,9 However, there is emerging evidence that
babies conceived through ART have an excess risk of con-
genital anomalies,12–14 which may independently contribute
to the risk of congenital anomaly among DZ twins.
The combination of twin pregnancy and congenital
anomaly can pose particular problems for the management
of the pregnancy and birth, where one or all of the fetuses/
babies in a multiple pregnancy are affected. Little is known
on a population basis about the rates of prenatal diagno-
sis15–18 and in utero and neonatal survival19,20 in twin preg-
nancies with congenital anomaly relative to singletons with
congenital anomaly.
This paper investigates how the change in the proportion
of multiple births over a 24-year period (1984–2007) in
European countries has affected the prevalence of congeni-
tal anomalies from multiple births, and the relative risk of
congenital anomaly in multiple versus singleton births. It
also investigates whether multiple pregnancy status affects
the likelihood of prenatal diagnosis of a fetus with congeni-
tal anomaly, and whether babies with congenital anomaly
from multiple pregnancies have a different outcome in
terms of in utero and early neonatal survival from their sin-
gleton counterparts (2000–07). The proportion of twin
pairs concordant for any type of congenital anomaly is
assessed, as well as the impact of concordance on the likeli-
hood of prenatal diagnosis or terminations of pregnancy
for fetal anomaly (TOPFA).
Methods
European Surveillance of Congenital Anomalies (EURO-
CAT) collects standardised data across Europe that can be
used to assess changes in the epidemiology of congenital
anomalies and associated risk factors. The EUROCAT central
database contains data on congenital anomaly cases from
population-based congenital anomaly registries.21 The meth-
ods of registry case ascertainment are fully described else-
where.22 The database includes congenital anomaly cases
among live births (LB), fetal deaths after 20 weeks of gesta-
tion (FD), and all prenatally diagnosed cases resulting in ter-
mination of pregnancy (TOPFA) at any gestational age.
Congenital anomaly cases diagnosed in spontaneous abor-
tion before 20 completed weeks of gestation are not included.
Nineteen registries in 14 countries participated in this study
(Table 1), all of which could provide data on multiple birth
status for both their cases and the population.23 These regis-
tries covered a population of 5.4 million births between 1984
and 2007. Not all registries cover the early part of the study
period (Table 1) and only 13 registries in eight countries
(Table 1) could provide data on like-sex and unlike-sex twin
pairs in the denominator data used to estimate zygosity pro-
portions in the population. Fourteen registries in eight coun-
tries (Table 1) were able to provide the maternal age
distribution of multiple and singleton denominator births.
The period 2000–07, covering a population of 3.2 million
births, was analysed as the most recent data.
A ‘case’ in this paper refers to fetus/baby diagnosed with
a congenital anomaly. Congenital anomalies are coded
within the range 740–759 in the International Classification
of Diseases, version 9 (ICD9) or in the Q chapter in
version 10 (ICD10).24 The EUROCAT Data Management
Programme assigns all major congenital anomalies to
subgroups according to their ICD codes.21 The analysis
presented here uses only the subgroups ‘all anomalies’, ‘all
nonchromosomal anomalies’ (i.e. cases where no chromo-
somal syndrome was diagnosed) and ‘chromosomal anom-
alies’. Cases with only minor anomalies, or patent ductus
arteriosus in preterm infants, are excluded according to a
specific list of exclusions.21
Cases were classified as prenatally or postnatally diag-
nosed, and according to pregnancy outcome (LB, FD,
TOPFA) and early neonatal death (deaths within 1 week)
among LB.
Multiple birth is defined for cases in EUROCAT guide-
lines according to the ‘number of babies/fetuses deliv-
ered’.21 As the diagnosis of multiple birth is often made on
early ultrasound scans, with subsequent loss of one fetus,25,
26 the registries were surveyed to ascertain how the EURO-
CAT guidelines are interpreted in case of early loss of a co-
twin. Fourteen centres were able to check their data and of
the 3980 cases from multiple births recorded, only 22
(0.55%) were singletons at delivery. Denominator data
were provided by the registries or were requested directly
from national birth registries. They are provided as LB and
stillbirths (SB) and reflect civil registration of births in the
area and country where the registry is situated. For births
(denominators), multiple birth is defined as declared at
civil registration.
Conjoined twins are included as multiple birth cases, but
the pair is only counted as one case. The prevalence of
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conjoined twins was calculated separately, and conjoined
twins were included in the analysis of nonchromosomal
cases.
EUROCAT data enable linkage of babies with congenital
anomalies from a multiple set where more than one is
affected. After a careful check for possible duplications,
concordant twins were defined as twin pairs where both of
the fetuses/babies in the pair had a congenital anomaly
within the subgroup of analysis (e.g. for the nonchromo-
somal anomaly subgroup, a concordant pair is one where
both babies have any nonchromosomal anomaly, but not
necessarily the same specific type of anomaly). When
examining concordance only twin pairs were used, exclud-
ing higher-order multiple births and conjoined twin pairs.
Concordance analyses were pair-based rather than case-
based.
Statistical analysis
Statistical analysis was performed using STATA version 9.0
(Statacorp LP, College Station, TX, USA).
Proportions of MZ and DZ twins among all (denomina-
tor) births were calculated for those registries with denomi-
nators giving like-sex and unlike-sex twin pairs using the
Weinberg rule: number of MZ pairs = total pairs  2
(unlike-sex pairs). This rule has been validated using popu-
lation-based twin registries where zygosity is known.27,28
The proportion of congenital anomaly cases among mul-
tiple births (live and still) was calculated as: [No. of con-
genital anomaly cases (LB+FD+TOPFA) that were from
multiple births or pregnancies 9 100]/[Total no. of multi-
ple births (LB + SB) in the population].
The prevalence of congenital anomaly from multiple
births per 10 000 births (live and still) in the population
was calculated as: [No. of congenital anomaly cases (LB
+FD+TOPFA) that were from multiple births or pregnan-
cies 9 10 000]/(Total no. LB+SB in the population).
Relative risks (RR) with 95% confidence intervals (95%
CI) were estimated using Poisson regression to represent
the ratio of the proportion of congenital anomalies among
multiple births relative to the proportion among singleton
births. The RRs were adjusted for country (Table 1) and
time. Data were categorised into six 4-year time periods
(1984–87, 1988–91, 1992–95, 1996–99, 2000–03 and 2004–
07) for the analysis of time trends. Poisson regression was
Table 1. Study population (countries and years), number and proportion of births covered by registries and % multiple, no. of congenital
anomaly cases registered and % from multiple births, 1984–2007
Country Percentage of
country covered by
EUROCAT registries
in study
Years for which
case and denominator
data are available
Total denominator births
and percentage multiple
Total number of
congenital anomaly
cases and percentage
multiple
Poland (Wielkopolska)* 9.8% 1999–2007 316 838 (2.27%) 7314 (3.43%)
Italy (Tuscany) 5.5% 2004–2007 119 482 (2.43%) 2352 (3.23%)
Germany (Saxony-Anhalt) 2.6% 2000–2007 140 710 (2.69%) 4593 (4.01%)
Malta*,** 100% 1999–2007 36 412 (2.80%) 1160 (3.19%)
Hungary* 100% 1998–2002 561 911 (2.73%) 12 580 (2.80%)
UK^ (four registries: NorCAS,
WANDA, CARIS, CAROBB)*,**
16.3% 1989–2007 1 110 594 (2.94%) 29 601 (3.62%)
Austria (Styria) 13.4% 1985–2007 275 733 (2.41%) 7849 (4.37%)
Ireland^^
(Three registries: Dublin, Cork
and Kerry, South east Ireland)*,**
62.7% 1984–2007 647 348 (2.72%) 15 073 (2.89%)
Switzerland (Vaud) 10.3% 1989–2007 142 366 (2.85%) 5371 (4.60%)
Belgium (Antwerp)*,** 16.5% 1990–2007 256 747 (3.63%) 6532 (5.28%)
France (Paris)* 3.2% 1984–2007 814 569 (3.36%) 24 754 (3.82%)
Northern Netherlands** 9.7% 1984–2007 420 045 (3.28%) 10 737 (3.97%
Norway*,** 100% 1999–2006 464 992 (3.66%) 17 261 (4.77%)
Denmark (Odense)** 8.5% 1984–2007 130 323 (3.58%) 3182 (5.09%)
Total 1984–2007 5 438 072 (3.00%) 148 359 (3.83%)
*Maternal age denominators available at the time of analysis.
**Like-sex data available (in Ireland this is for two out of the three registries).
^Years included NorCAS 2000–2007, WANDA 1994–2007, Wales 1998–2007 and CAROBB 1991–2007.
^^Dublin 1984–2007, Cork and Kerry 1996–2004, South east Ireland 1997–2007.
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used because of the rarity of the events studied and the
possibility of no events happening within a given time per-
iod.29
A subanalysis was performed, adjusting for maternal age
(<20, 20–24, 25–29, 30–34, 35–39, 40–44 and >44 years)
for those countries for which maternal age denominators
were available.
Logistic regression was used to estimate odds ratios
(OR) adjusted for country when analysing the odds of
prenatal diagnosis and of various pregnancy outcomes.
These analyses used case data only because they com-
pared multiple cases with singleton cases. Odds of SB
(versus LB) and early neonatal death (versus surviving
LB) in multiple versus singleton pregnancies were also
analysed, stratified by gestational age ( 35 weeks or
 36 weeks of gestation). Although preterm birth is usu-
ally defined as before 37 weeks, 36 weeks was used
because placental maturation occurs earlier in multiple
pregnancies.30, 31
The proportion of concordant pairs was calculated for
twin pairs only and for 2000–07 only as: (Pairs where both
babies or fetuses were cases 9 100)/(No. of twin pairs from
which at least one case was diagnosed).
Results
Of the 5.4 million births during the 24-year study period,
3.00% of babies were from multiple births (Table 1), vary-
ing by country (Table 1). Of the 148 359 births involving
major congenital anomalies recorded in this population,
3.83% were from multiple births (Table 1, see Supplemen-
tary material, Appendix S1 for 2000–07 only). Chromo-
somal anomalies represented 12.8% of congenital
anomalies among singleton births, and 7.43% among mul-
tiple births. The prevalence of conjoined twins was 0.19 per
10 000 births (n = 103).
Trends in multiple births and zygosity in the
denominator (births) data
The percentage of babies who were from multiple births
rose from 2.32% to 3.09% between 1984–87 and 2004–07
(Figure 1). The rise, which mainly occurred in the late
1980s and plateaued thereafter, varied between countries
(Figure 1). The estimated proportion of MZ twins among
all births varied between 0.76% and 0.96% but showed no
overall trend, whereas the proportion of DZ twins among
all births rose, with a similar plateau, from 1.43% to 1.93%
(Figure 2).
Trends in prevalence of congenital anomaly in
multiple births and relative risk compared with
singleton births 1984–2007
The prevalence of cases of congenital anomaly from multi-
ple births increased from 5.60 per 10 000 births in 1984–87
to 10.9 per 10 000 in 2004–07, peaking at 11.5 per 10 000
births in 2000–03 (P < 0.001, Table 2), with variation
between countries (Figure 3). Nonchromosomal anomalies
from multiple births increased from 5.03 per 10 000 births
to 10.0 per 10 000 births over the same period (P < 0.001,
Table 2). The prevalence of chromosomal anomalies from
multiple births increased from 0.58 per 10 000 births to
0.90 per 10 000 births (P = 0.037, Table 2).
The proportion of congenital anomaly cases in multiple
births was 3.49% (95% CI 3.40–3.55%) compared with
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Figure 1. Proportion (%) of multiple births in the EUROCAT population: 1984–2007.
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2.70% (95% CI 2.69–2.72%) in singleton births. The rela-
tive risk of congenital anomaly in multiple versus singleton
births adjusted for country and time (adjRR) was 1.27
(95% CI 1.24–1.30) (Table 2).
The proportion of nonchromosomal congenital anomaly
cases in multiple births was 3.23% (95% CI 3.14–3.328%)
compared with 2.35% (95% CI 2.34–2.37%) in singleton
births. Relative risk of nonchromosomal anomaly in multi-
ple versus singleton births, adjusted for country and time,
was adjRR 1.35 (95% CI 1.31–1.39) overall, increasing over
time from adjRR 1.06 (95% CI 0.92–1.22) for 1984–87 to
adjRR 1.41 (95% CI 1.34–1.48) for 2004–07 (Figure 4).
The overall proportion of chromosomal anomalies in
multiple births was 0.26% (95% CI 0.24–0.29%) compared
with 0.35% (95% CI 0.34–0.35%) in singleton births. Rela-
tive risk of chromosomal anomalies in multiple versus sin-
gleton births, adjusted for country and time, was adjRR
0.72 (95% CI 0.65–0.80), decreasing over time from adjRR
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Figure 2. Estimated proportion of births (babies) who were
monozygotic and dizygotic twins: 1984–2007 (see Table 1 for registries
with data on like-sex and unlike-sex births on which this figure is
based, using Weinberg rule).
Table 2. Number and prevalence of cases from multiple births per 10 000 births and proportion (%) of cases in multiple and singleton births for
all, nonchromosomal and chromosomal cases and RR of cases in multiple relative to singleton births 1984–2007, by 4-year time period
Congenital anomaly cases from multiple pregnancies Congenital anomaly cases
from singleton pregnancies
RR congenital
anomaly in
multiple relative
to singleton
births*
Year-groups Number Prev/10 000 births 95% CI % multiple births Number % singleton births RR 95% CI
All congenital anomaly cases
1984–87 185 5.60 4.85–6.47 2.41 7359 2.28 1.06 0.91–1.22
1988–91 350 8.58 7.72–9.52 3.19 10 543 2.65 1.19 1.07–1.33
1992–95 581 11.3 10.4–12.2 3.67 13 905 2.79 1.31 1.20–1.42
1996–99 1040 10.1 9.45–10.7 3.28 26 847 2.68 1.20 1.13–1.27
2000–03 1934 11.5 11.0–12.1 3.74 46 042 2.83 1.30 1.25–1.36
2004–07 1603 10.9 10.4–11.5 3.55 37 968 2.66 1.31 1.24–1.38
Total 5695 10.5 10.2–10.8 3.49 142 664 2.70 1.27 1.24–1.30
Nonchromosomal anomalies
1984–87 166 5.03 4.32–5.85 2.16 6539 2.03 1.07 0.92–1.25
1988–91 320 7.82 7.01–8.72 2.91 9221 2.31 1.25 1.12–1.39
1992–95 528 10.3 9.42–11.2 3.34 12 014 2.41 1.37 1.26–1.50
1996–99 948 9.16 8.59–9.76 2.99 23 430 2.33 1.26 1.18–1.34
2000–03 1883 10.9 10.4–11.4 3.54 40 629 2.50 1.40 1.34–1.47
2004–07 1472 10.1 9.51–10.5 3.26 32 386 2.27 1.41 1.34–1.48
Total 5268 9.68 9.42–9.95 3.23 124 219 2.35 1.35 1.31–1.39
Chromosomal anomalies
1984–87 19 0.58 0.37–0.90 0.25 820 0.25 0.97 0.61–1.52
1988–91 30 0.73 0.49–1.05 0.27 1322 0.33 0.83 0.58–1.18
1992–95 53 1.03 0.79–1.35 0.33 1891 0.38 0.87 0.66–1.14
1996–99 92 0.89 0.72–1.09 0.29 3417 0.34 0.81 0.66–1.01
2000–03 101 0.60 0.50–0.73 0.20 5413 0.33 0.57 0.47–0.70
2004–07 131 0.90 0.76–1.06 0.29 5582 0.39 0.71 0.60–0.78
Total 426 0.79 0.71–0.86 0.26 18 445 0.35 0.72 0.65–0.80
*Adjusted for country, total adjusted for country and time.
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0.97 (95% CI 0.61–1.52) for 1984–87 to adjRR 0.71 (95%
CI 0.60–0.78) for 2004–07 (Figure 4).
A subanalysis of RR adjusted for maternal age was per-
formed for countries with maternal age denominator data.
This adjustment resulted in almost no change for nonchro-
mosomal anomalies [a change from unadjusted RR 1.31
(95% CI 1.26–1.36) to adjRR 1.33 (1.28–1.38)] and an
increased risk deficit for chromosomal anomalies [unad-
justed OR 0.72 (95% CI 0.40–0.81) to adjOR 0.64 (95% CI
0.57–0.72)].
Concordance 2000–07
The 2000–07 data for twin pairs with at least one nonchro-
mosomal case (n = 2665), showed a proportion of concor-
dant pairs (where both babies were diagnosed with a
nonchromosomal congenital anomaly) of 11.6%. Converted
to babies, this means that 20.8% of cases with a nonchro-
mosomal anomaly from a multiple birth have an affected
co-twin.
For pairs with at least one chromosomal anomaly case
(n = 217), 5.53% of pairs were concordant. In terms of
babies, 10.5% of cases with a chromosomal anomaly from
a multiple birth are from a concordant pair.
There were seven pairs (0.2% of all affected twin pairs)
where one baby had a chromosomal anomaly and the other
had a nonchromosomal anomaly. In total, concordance for
all twin pairs with at least one congenital anomaly case was
11.4%.
Prenatal diagnosis 2000–07
Prenatal diagnosis did not significantly differ between
cases from multiple births and singleton pregnancies [ad-
jOR 0.97 (95% CI 0.89–1.06)], but were less likely to
result in TOPFA [adjOR 0.41 (95% CI 0.35–0.48)]. This
was found for both nonchromosomal and chromosomal
anomalies, but chromosomal anomalies had a particularly
reduced TOPFA frequency [adjOR 0.21 (95% CI 0.14–
0.31), Table 3].
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Figure 3. Prevalence of congenital anomaly cases from multiple births per 10 000 births: 1984–2007.
Figure 4. Risk of congenital anomaly in babies from multiple births relative to singletons: 1984–2007, for nonchromosomal and chromosomal
anomalies separately.
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Of prenatally diagnosed nonconcordant pairs where one
baby had a nonchromosomal anomaly, 16.2% (n = 89
pairs) resulted in TOPFA (i.e. selective feticide), compared
with 26.6% (n = 34 pairs) in concordant pairs. For chro-
mosomal anomalies, these proportions were 48.1%
(n = 50) for nonconcordant, and 22.2% (n = 2) for con-
cordant pairs.
Pregnancy outcome 2000–07
Of congenital anomaly cases from multiple pregnancies,
88.7% resulted in an LB, compared with 84.4% for single-
tons (Table 4). The greater proportion of LB in cases from
multiple births was mainly explained by the lower TOPFA
proportion in multiple births.
Babies with congenital anomalies from multiple births
were born at earlier gestational ages than those from single-
ton births with 51.5% of cases from multiple births (once
TOPFAs were excluded) born before 36 weeks of gestation
compared with 11.3% of those from singleton births
(Table 4). Gestational age <36 weeks was associated with
greater mortality (both SB and early neonatal death) than
gestational age  36 weeks for both multiple and singleton
congenital anomaly cases, but mortality was lower for mul-
tiple than singleton congenital anomaly cases born before
36 weeks of gestation (Table 4).
Babies from multiple births with congenital anomalies
were more than twice as likely to be SB than LB compared
with their singleton counterparts [OR 2.55 (95% CI 2.16–
3.02), Table 4], and more than twice as likely to be early
neonatal deaths rather than surviving LB [OR 2.36 (95%
CI 1.97–2.82), Table 4]. Overall, the increased SB and neo-
natal death rate for multiple births with congenital anom-
aly was a combination of mortality associated with more
preterm birth, and greater mortality than singletons among
term births (Table 4).
Patterns of mortality differences were similar for non-
chromosomal and chromosomal cases (data not shown,
available on request).
Discussion
Interpretation of main findings
Within the European population studied, there was an
approximately 50% rise in the multiple birth rate, reflecting
trends reported by EUROPERISTAT,32 accompanied by a
70% rise in prevalence of congenital anomaly cases from
multiple births from 1984 to 2007. Most of the rise happened
in the 1980s. The risk of congenital anomalies was 27%
higher in multiple births than singleton births and this excess
risk also increased over time, again mainly in the 1980s.
If excess congenital anomaly risk were associated with
MZ twinning alone, given that the rise in the rate of multi-
ple births is in the rate of DZ twins, we should find a
decrease over time in the relative risk of congenital anom-
aly in multiple (MZ + DZ) versus singleton birth, whereas
we find the contrary—an increase. This suggests that DZ
twins may also be at higher risk of congenital anomaly,
and it is possible that this risk increase is related to
ART12,13 or to parental characteristics associated with
ART,14 rather than with multiple birth status per se. If
ART is associated with some of the excess risk identified,
then the increasing adoption of single-embryo-transfer pol-
icies33 may simply redistribute the risk of congenital anom-
aly to singletons.
In contrast with nonchromosomal anomalies, we
found a deficit of chromosomal cases from multiple births.
Table 3. Numbers and proportions of prenatally diagnosed (PD) cases, number and proportion of terminations of pregnancy for fetal anomaly
(TOPFA), and OR comparing cases from multiple births with singleton cases, 12 European countries*, 2000–07
Congenital anomaly group PD/TOPFA Number and proportion
(%) among
singleton births
Number and
proportion (%)
among multiple births
OR (95% CI) **
All congenital anomalies Prenatal diagnosis 21 696 (34.0) 858 (32.9) 0.97 (0.89–1.06)
TOPFA following prenatal
diagnosis
9559 (44.0) 213 (24.8) 0.41 (0.35–0.48)
Nonchromosomal anomalies Prenatal diagnosis 15 688 (28.9) 737 (30.7) 1.08 (0.99–1.18)
TOPFA following prenatal
diagnosis
4779 (30.5) 159 (21.6) 0.60 (0.50–0.72)
Chromosomal anomalies Prenatal diagnosis 6025 (62.8) 121 (59.6) 0.94 (0.68–1.31)
TOPFA following prenatal
diagnosis
4780 (79.3) 54 (44.6) 0.21 (0.14–0.31)
*Norwegian and Hungarian data excluded because prenatal diagnosis data were not available.
**Adjusted for country.
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A deficit has been previously reported4,7 but nevertheless
seems not to be widely known. We found that the main
reduction was in number of concordant pairs/cases from
MZ twins. Given the paucity of evidence on multiple births
for use in prenatal screening algorithms,17 this finding is
being further detailed in a study on Down syndrome,
which enlarges the study population further. Interpretation
is complex, as it involves consideration of maternal age,
zygosity and ART including egg donation, use of eggs fro-
zen at a younger maternal age and preimplantation diagno-
sis. The low concordance we find suggests selective loss of
affected fetuses in early pregnancy, before diagnosis, partic-
ularly in concordant MZ twins.34
Despite the greater technical and organisational problems
in twin or multiple pregnancies,15–18 prenatal diagnosis rates
for congenital anomalies were similar between cases from
singleton and multiple pregnancies. After prenatal diagnosis,
termination was much less likely to be the outcome in mul-
tiple than singleton pregnancies as an unaffected co-twin
must often be considered. Cases from multiple births were
more likely to die in the perinatal period than their single-
ton counterparts, partly associated with their much greater
preterm delivery rate and partly associated with higher mor-
tality rates at term. The balance of congenital anomaly and
survival is complex as it is confounded by the obstetric
choices that surround multiple births.35–37 Moreover,
because of the lower TOPFA rate, the proportion of lethal
and very severe anomaly cases surviving to LB or SB is likely
to be higher in multiple birth cases, so affecting perinatal
mortality rates.9 Concordant pairs were more likely to result
in termination than cases from nonconcordant pairs, pre-
sumably as the need to consider the co-twin is lessened. The
difference in outcomes between cases from multiple and
singleton births suggests that, although single embryo trans-
fer may not influence the overall number of congenital
anomaly cases, it may affect the pregnancy outcomes for
those cases from ART pregnancies.
Strengths and limitations
The strengths of this study relate to its large population
coverage in Europe, with high-quality diagnostic data on
congenital anomalies that were collected from multiple
sources and coded consistently. The main study limitation
relates to the lack of individual information on zygosity,
for both cases and births, and the lack of systematic data
on ART for cases and for births. An important methodo-
logical issue in this type of study is the definition of a mul-
tiple birth. Earlier in pregnancy, more pregnancies are
multiple; some of these experience loss of one fetus leading
to a singleton delivery.38 We validated our case data to
make sure that ‘multiple’ status was at delivery, not early
pregnancy, and would therefore be comparable to data
from birth registrations.
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There are differences between registries in ascertainment
of congenital anomaly cases, because of differences in
screening and diagnosis, and differences in completeness of
access to appropriate medical records,22, 39 and so we strat-
ified analyses for registry. Multiple birth status for cases
may sometimes have been unstated in the medical records
leading to slight underestimation of RR. Multiple births
may be subject to more prenatal screening18 than singletons
(although we found a similar prenatal diagnosis rate) or
more paediatric examination because of longer hospital
stays associated with preterm birth, but our data concern
major anomalies that are normally diagnosed prenatally or
neonatally.
Implications for service provision
The co-occurrence of multiple birth and congenital anom-
aly among liveborn infants places particular demands on
parents and health services. This may be even more rele-
vant for the one in nine affected twin pairs where both
babies are affected by a congenital anomaly. Parental inter-
actions encouraging normal development are more difficult
with twins40 and such interaction may be particularly
important for babies with a congenital anomaly, potentially
requiring ongoing treatment.41,42 Extra specialised help
should be put in place for affected families, recognising
that there are now nearly twice as many affected families
than there were 20 years ago, although absolute numbers
are small, at one per 1000 births.
Women with MZ twin pregnancies can be counselled
that they have a small excess risk of a major congenital
anomaly (per baby), usually with only one baby affected,
but a lower risk of chromosomal anomaly (per baby), com-
pared with women with singleton pregnancies. For women
with DZ pregnancies, further research is needed to deter-
mine whether any excess risk of nonchromosomal congeni-
tal anomaly is limited to those following ART.
Conclusions
We found a small excess risk of nonchromosomal congeni-
tal anomaly in multiple births, an excess that increased par-
ticularly during the 1980s, possibly because of ART. We
found a lower risk of chromosomal anomaly among multi-
ple births than singletons, which needs further investigation
before it can be fully taken into account for prenatal
screening. The rate of prenatal diagnosis was similar for
multiple and singleton pregnancies, but TOPFA following
prenatal diagnosis was much less commonly chosen in
multiple pregnancies, and this, as well as the higher pre-
term rate, contributed to higher SB and neonatal mortality.
The co-occurrence of multiple birth and congenital anoma-
lies is now twice as common as in the mid-1980s, at 1 per
1000 babies. A single-embryo-transfer policy may not
reduce the number of babies with congenital anomalies in
the population, but may affect pregnancy course and neo-
natal outcome and reduce the extra demands placed on
services and on parents by co-occurrence of multiple birth
and congenital anomaly.
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